De Giorgi R, Ghenciulescu A, Yotter C, Taquet M, Koychev I (2025) Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
After the 56-week treatment period, BMI standard deviation scores (BMI SDS) decreased by a mean of 0.23 in the liraglutide group, with no change in the placebo group
Physicians at Loma Linda University Health say the medications are also helping many men improve their overall health, from diabetes and heart disease risk to sleep apnea and hormone health
Increasing the number of intestinal endocrine L-cells According to the impairment of L-cells development in T2DM, a promising strategy for treating T2DM is to increase the number of L-cells in the intestine, thereby increasing the production of GLP-1
Designed for daily use, our easy-to-apply patch bypasses the digestive system and delivers nutrients directly into your bloodstream, supporting optimal absorptionwithout the pills, nausea, or GI upset